These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10718781)

  • 1. Dutch hospital drug formularies: pharmacotherapeutic variation and conservatism, but concurrence with national pharmacotherapeutic guidelines.
    Fijn R; Engels SA; Brouwers JR; Knaap RJ; De Jong-Van den Berg LT
    Br J Clin Pharmacol; 2000 Mar; 49(3):254-63. PubMed ID: 10718781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to hospital drug formularies and cost of drugs in hospitals in Denmark.
    Plet HT; Hallas J; Kjeldsen LJ
    Eur J Clin Pharmacol; 2013 Oct; 69(10):1837-43. PubMed ID: 23765410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The quality of Dutch hospital drug formularies: evaluation of technical features and organisational information.
    Fijn R; de Vries CS; Engels SA; Brouwers JR; de Blaey CJ; de Jong-van den Berg LT
    Pharm World Sci; 1999 Jun; 21(3):120-6. PubMed ID: 10427581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of indicators for hospital drug formulary non-adherence.
    Fijn R; Lenderink AW; Egberts AC; Brouwers JR; De Jong-Van DenBerg LT
    Eur J Clin Pharmacol; 2001 Nov; 57(9):677-84. PubMed ID: 11791899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic guidelines and antibiotic utilization in Dutch hospitals.
    Stobberingh E; Janknegt R; Wijnands G
    J Antimicrob Chemother; 1993 Jul; 32(1):153-61. PubMed ID: 8226406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational pharmacotherapy in The Netherlands: formulary management in Dutch hospitals.
    Fijn R; de Jong-van den Berg LT; Brouwers JR
    Pharm World Sci; 1999 Apr; 21(2):74-9. PubMed ID: 10380234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug and therapeutics committees in Danish hospitals: a survey of organization, activities and drug selection procedures.
    Plet HT; Hallas J; Nielsen GS; Kjeldsen LJ
    Basic Clin Pharmacol Toxicol; 2013 Apr; 112(4):264-9. PubMed ID: 23107106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personal formularies. An index of prescribing quality?
    Robertson J; Fryer JL; O'Connell DL; Smith AJ; Henry DA
    Eur J Clin Pharmacol; 2001 Jul; 57(4):333-41. PubMed ID: 11549213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing patterns of initial drug therapy for the treatment of hypertension in a Medicaid population, 1997-2000.
    Weiss R; Buckley K; Clifford T
    Clin Ther; 2002 Sep; 24(9):1451-62. PubMed ID: 12380636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
    Yıldız M; Osman E
    Turk Psikiyatri Derg; 2022; 33(2):146-148. PubMed ID: 35730516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug selection in French university hospitals: analysis of formularies for nine competitive pharmacological classes.
    Gallini A; Juillard-Condat B; Saux MC; Taboulet F
    Br J Clin Pharmacol; 2011 Nov; 72(5):823-31. PubMed ID: 21518387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of follow-on drugs and indications on the WHO Essential Drug List.
    Cohen J; Cabanilla L; Sosnov J
    J Clin Pharm Ther; 2006 Dec; 31(6):585-92. PubMed ID: 17176363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do baby-friendly hospitals influence breastfeeding duration on a national level?
    Merten S; Dratva J; Ackermann-Liebrich U
    Pediatrics; 2005 Nov; 116(5):e702-8. PubMed ID: 16263985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National drug formularies: lessons from Latin America.
    LeRoy AA; Morse ML
    Drug Inf J; 1983; 17(2):89-94. PubMed ID: 10263720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General practitioners choose within a narrow range of drugs when initiating new treatments: a cohort study of cardiovascular drug formularies.
    Buusman A; Kragstrup J; Andersen M
    Eur J Clin Pharmacol; 2005 Oct; 61(9):651-6. PubMed ID: 16187132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying widely covered drugs and drug coverage variation among Medicare part D formularies.
    Tseng CW; Mangione CM; Brook RH; Keeler E; Dudley RA
    JAMA; 2007 Jun; 297(23):2596-602. PubMed ID: 17579228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of European Society of Cardiology guidelines on medication profiles after hospitalization for heart failure in 22,476 Dutch patients: from 2001 until 2015.
    Kruik-Kollöffel WJ; Linssen GCM; Kruik HJ; Movig KLL; Heintjes EM; van der Palen J
    Heart Fail Rev; 2019 Jul; 24(4):499-510. PubMed ID: 30848404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and activities of hospital drug committees in Germany.
    Thürmann PA; Harder S; Steioff A
    Eur J Clin Pharmacol; 1997; 52(6):429-35. PubMed ID: 9342577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication Initiation Burden Required to Comply With Heart Failure Guideline Recommendations and Hospital Quality Measures.
    Allen LA; Fonarow GC; Liang L; Schulte PJ; Masoudi FA; Rumsfeld JS; Ho PM; Eapen ZJ; Hernandez AF; Heidenreich PA; Bhatt DL; Peterson ED; Krumholz HM;
    Circulation; 2015 Oct; 132(14):1347-53. PubMed ID: 26316616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.